How are patients’ preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn’s disease patients-Reference-Cited by-同舟云学术

How are patients’ preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn’s disease patients

Published:2022-06-18 Issue:11 Volume:57 Page:1312-1320
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Brunet-Houdard Solène¹²^ORCID,Monmousseau Fanny¹²^ORCID,Berthon Geoffrey¹,Des Garets Véronique³,Laharie David⁴,Picon Laurence⁵,Fotsing Ginette⁶,Gargot Dany⁷,Charpentier Cloé⁸,Buisson Anthony⁹^ORCID,Trang-Poisson Caroline¹⁰,Dib Nina¹¹,Rusch Emmanuel¹²,Aubourg Alexandre⁵,

Affiliation:

1. Health Economic Evaluation Unit, University Hospital of Tours, Tours, France

2. EA7505 Education, Ethics, Health Research Unit, University of Tours, Tours, France

3. EA6296 VALLOREM Loire Valley Management Research Unit, Loire Valley University Management School, University of Tours, Tours, France

4. Department of Gastroenterology, University Hospital of Bordeaux, Pessac, France

5. Department of Gastroenterology, University Hospital of Tours, Chambray-lès-Tours, France

6. Department of Gastroenterology, University Hospital of Poitiers, Poitiers, France

7. Department of Gastroenterology, Hospital of Blois, Blois, France

8. Department of Gastroenterology, University Hospital of Rouen, Rouen, France

9. Department of Gastroenterology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

10. Department of Gastroenterology, University Hospital of Nantes, Nantes, France

11. Department of Gastroenterology, University Hospital of Angers, Angers, France

Funder

University of Tours

Centre-Val de Loire region

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2022.2085057

Reference50 articles.

1. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

2. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

3. Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience

4. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn’s fistulas

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge;Journal of Clinical Medicine;2024-02-27

2. ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease;Journal of Crohn's and Colitis;2023-01-10